SynthesisFrontiers in medicine2026
Association between serum vitamin D levels and the risk of diabetic retinopathy: a meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This meta-analysis was conducted to quantitatively synthesize existing evidence on the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and diabetic retinopathy (DR). Methods: A systematic search of PubMed, Embase, the Web of Science, and the Cochrane Library was performed for obtaining observational studies published between January 2015 and February 2026. The included studies reported adjusted effect estimates for the association between 25(OH)D levels and DR. A random-effects model was used to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Subgroup analysis was performed to explore the sources of heterogeneity based on ethnicity, diabetes type, study design, and vitamin D assay method. A sensitivity analysis was conducted to evaluate the robustness of the pooled results. Publication bias was assessed using Begg's funnel plot and Egger's linear regression test. Results: This meta-analysis included 16 relevant studies, and the pooled results showed that low serum vitamin D levels were associated with a higher likelihood of developing DR (OR = 1.87, 95% CI: 1.66-2.11). Subgroup analyses revealed stronger effect sizes in Asian populations (OR = 1.97, 95% CI: 1.63-2.38) and type 1 diabetes mellitus (T1DM) patients (OR = 2.15, 95% CI: 1.70-2.72). The sensitivity analysis confirmed the robustness of the findings, and publication bias was not observed. Conclusion: Low vitamin D levels were associated with higher odds of developing DR, and this association was particularly evident in Asian individuals and T1DM patients. These findings suggest the importance of monitoring vitamin D levels in the management of DR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.